Literature DB >> 7982965

Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils.

I M Ferby1, I Waga, C Sakanaka, K Kume, T Shimizu.   

Abstract

Stimulation of guinea pig neutrophils with platelet-activating factor (PAF) caused a rapid and transient activation of mitogen-activated protein kinase (MAPK). Wortmannin, an inhibitor of phosphatidylinositol 3-kinase, partially (approximately 50%) inhibited PAF-induced MAPK activation. Half-maximal inhibition was observed with 200-300 nM wortmannin, while it did not inhibit phorbol ester-induced MAPK activation. Neutrophils preloaded with 1,2-bis-(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester (BAPTA/AM) failed to raise cytosolic Ca2+ concentrations toward PAF, while they still responded to PAF with a 40-50% activation of MAPK. However, when cells were treated with BAPTA/AM and wortmannin in combination, the MAPK activation was completely inhibited. These results suggest that PAF activates MAPK through two distinct pathways in guinea pig neutrophils, one Ca(2+)-dependent, and the other Ca(2+)-independent but wortmannin-sensitive.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982965

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Mitogenic signalling by delta opioid receptors expressed in rat-1 fibroblasts involves activation of the p70s6k/p85s6k S6 kinase.

Authors:  M A Wilson; A R Burt; G Milligan; N G Anderson
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Enhanced survival of melanopsin-expressing retinal ganglion cells after injury is associated with the PI3 K/Akt pathway.

Authors:  Suk-Yee Li; Suk-Yu Yau; Bai-Yu Chen; David K Tay; Vincent W H Lee; Ming-Liang Pu; Henry H L Chan; Kwok-Fai So
Journal:  Cell Mol Neurobiol       Date:  2008-05-30       Impact factor: 5.046

3.  Functional interactions of phosphatidylinositol 3-kinase with GTPase-activating protein in 3T3-L1 adipocytes.

Authors:  D DePaolo; J E Reusch; K Carel; P Bhuripanyo; J W Leitner; B Draznin
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 4.  Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.

Authors:  David R Raleigh; Daphne A Haas-Kogan
Journal:  Future Oncol       Date:  2013-02       Impact factor: 3.404

5.  Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.

Authors:  G J Brunn; J Williams; C Sabers; G Wiederrecht; J C Lawrence; R T Abraham
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Gi2-mediated activation of the MAP kinase cascade.

Authors:  A M Pace; M Faure; H R Bourne
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

7.  Regulation of interleukin-5-induced beta2-integrin adhesion of human eosinophils by phosphoinositide 3-kinase.

Authors:  Masaaki Sano; Alan R Leff; Shigeharu Myou; Evan Boetticher; Angelo Y Meliton; Jonathan Learoyd; Anissa T Lambertino; Nilda M Munoz; Xiangdong Zhu
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-31       Impact factor: 6.914

8.  Functional coupling of adenosine A2a receptor to inhibition of the mitogen-activated protein kinase cascade in Chinese hamster ovary cells.

Authors:  D Hirano; Y Aoki; H Ogasawara; H Kodama; I Waga; C Sakanaka; T Shimizu; M Nakamura
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

9.  The volume-activated chloride current in endothelial cells from bovine pulmonary artery is not modulated by phosphorylation.

Authors:  G Szücs; S Heinke; C De Greef; L Raeymaekers; J Eggermont; G Droogmans; B Nilius
Journal:  Pflugers Arch       Date:  1996-02       Impact factor: 3.657

10.  CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.

Authors:  Bikash Sahay; Rebeca L Patsey; Christian H Eggers; Juan C Salazar; Justin D Radolf; Timothy J Sellati
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.